/ Biologics · Synthetics · Peptides

We've worked with what you actually manufacture.

  1. Drug research and development.

  2. Peptide synthesis (SPPS).

  3. Vaccines QA, USP/ (cell-based).

  4. Human/Animal antibodies and albumin purification, production and quality control.

  5. Antivenoms design, formulation, production and quality control.

  6. Proteins separation, purification and identification.

  7. Venoms biochemical, immunochemical and pharmacological characterization.

  8. Venomous animals handling (Spiders, snakes and scorpions), including manual extraction of the venom.

Close-up overhead shot of gloved hands positioning a glass vial in a stainless steel fill-finish carousel under steady facility fluorescent light, pharmaceutical manufacturing cleanroom, precise industrial framing, documentary style
Close-up overhead shot of gloved hands positioning a glass vial in a stainless steel fill-finish carousel under steady facility fluorescent light, pharmaceutical manufacturing cleanroom, precise industrial framing, documentary style

— Why biologics are different

A vial of antivenom is not a tablet.

Biological products derived from plasma or venom require facility classifications, bioburden monitoring, and cold-chain documentation that differ fundamentally from solid-dose manufacturing. Most consultants have never authored those protocols.

We have written the SOPs, managed the fill-finish validations, and supported inspections in facilities that produce these products at commercial scale.

That specificity is not a niche. For manufacturers of antivenins or hemoderivates, it is the minimum standard for audit readiness.

Scope of product expertise

Three product families. One compliance framework.

Biologics

Synthetic Medicaments

Peptide-Based Drugs

Antivenoms and plasma-derived hemoderivates. We cover facility classification, bioburden protocols, cold-chain validation, and batch record authorship for venom-sourced and blood-derived products.

Complex synthesis, purification controls, and stability documentation for peptide APIs. We work from development-phase documentation through commercial-scale manufacturing records and inspection readiness.

Solid-dose and sterile injectable synthetics. GxP documentation, process validation, and staff training aligned to ICH Q7, Q8, and regional regulatory requirements across your target markets.

Review Our Services
From floor to record

The vocabulary of your manufacturing floor.

Fill-finish validation. Bioburden monitoring. Batch record review. Environmental monitoring programs. These are not abstractions—they are the deliverables your auditors will read.

Our engagements run until your team owns the documentation and can defend it under inspection—not until our contract ends.